A novel Anti-ROS osteoblast-specific supply system for ankylosing spondylitis therapy through suppression of each irritation and pathological new bone formation | Journal of Nanobiotechnology


  • Ward MM, Deodhar A, Gensler LS, Dubreuil M, Yu D, Khan MA, Haroon N, Borenstein D, Wang R, Biehl A, Fang MA, Louie G, Majithia V, Ng B, Bigham R, Pianin M, Shah AA, Sullivan N, Turgunbaev M, Oristaglio J, Turner A, Maksymowych WP, Caplan L. 2019 replace of the American School of Rheumatology/Spondylitis Affiliation of America/Spondyloarthritis Analysis and Remedy Community Suggestions for the therapy of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis. Arthritis Rheumatol. 2019;71(10):1599–613.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • van der Heijde D, Kivitz A, Schiff MH, Sieper J, Dijkmans BA, Braun J, Dougados M, Reveille JD, Wong RL, Kupper H, Davis JC Jr, Group AS. Efficacy and security of adalimumab in sufferers with ankylosing spondylitis: outcomes of a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2006;54(7):2136–46.

    Article 
    PubMed 

    Google Scholar
     

  • Sieper J, Poddubnyy D. Axial spondyloarthritis. Lancet. 2017;390(10089):73–84.

    Article 
    PubMed 

    Google Scholar
     

  • Inman RD, Davis JC Jr, Heijde D, Diekman L, Sieper J, Kim SI, Mack M, Han J, Visvanathan S, Xu Z, Hsu B, Beutler A, Braun J. Efficacy and security of golimumab in sufferers with ankylosing spondylitis: outcomes of a randomized, double-blind, placebo-controlled, section III trial. Arthritis Rheum. 2008;58(11):3402–12.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Manabe H, Nasu Y, Komiyama T, Furumatsu T, Kitamura A, Miyazawa S, Ninomiya Y, Ozaki T, Asahara H, Nishida Okay. Inhibition of histone deacetylase down-regulates the expression of hypoxia-induced vascular endothelial progress issue by rheumatoid synovial fibroblasts. Inflamm Res. 2008;57(1):4–10.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Schett G, Lories RJ, D’Agostino MA, Elewaut D, Kirkham B, Soriano ER, McGonagle D. Enthesitis: from pathophysiology to therapy. Nat Rev Rheumatol. 2017;13(12):731–41.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Shankar J, Thippegowda PB, Kanum SA. Inhibition of HIF-1alpha exercise by BP-1 ameliorates adjuvant induced arthritis in rats. Biochem Biophys Res Commun. 2009;387(2):223–8.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Braun J, Brandt J, Itemizing J, Zink A, Alten R, Golder W, Gromnica-Ihle E, Kellner H, Krause A, Schneider M, Sorensen H, Zeidler H, Thriene W, Sieper J. Remedy of lively ankylosing spondylitis with infliximab: a randomised managed multicentre trial. Lancet. 2002;359(9313):1187–93.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Cramer T, Yamanishi Y, Clausen BE, Forster I, Pawlinski R, Mackman N, Haase VH, Jaenisch R, Corr M, Nizet V, Firestein GS, Gerber HP, Ferrara N, Johnson RS. HIF-1alpha is important for myeloid cell-mediated irritation. Cell. 2003;112(5):645–57.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Davis JC Jr, Van Der Heijde D, Braun J, Dougados M, Cush J, Clegg DO, Kivitz A, Fleischmann R, Inman R, Tsuji W. Enbrel Ankylosing Spondylitis Examine, recombinant human tumor necrosis issue receptor (etanercept) for treating ankylosing spondylitis: a randomized, managed trial. Arthritis Rheum. 2003;48(11):3230–6.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Baraliakos X, Heldmann F, Callhoff J, Itemizing J, Appelboom T, Brandt J, Van den Bosch F, Breban M, Burmester G, Dougados M, Emery P, Gaston H, Grunke M, Van Der Horst-Bruinsma IE, Landewe R, Leirisalo-Repo M, Sieper J, De Vlam Okay, Pappas D, Kiltz U, Van Der Heijde D, Braun J. Which spinal lesions are related to new bone formation in sufferers with ankylosing spondylitis handled with anti-TNF brokers? A protracted-term observational examine utilizing MRI and traditional radiography. Ann Rheum Dis. 2014;73(10):1819–25.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Maksymowych WP. Illness modification in ankylosing spondylitis. Nat Rev Rheumatol. 2010;6(2):75–81.

    Article 
    PubMed 

    Google Scholar
     

  • van der Heijde D, Landewe R, Baraliakos X, Houben H, van Tubergen A, Williamson P, Xu W, Baker D, Goldstein N, Braun J. Ankylosing Spondylitis Examine for the analysis of recombinant infliximab remedy examine, radiographic findings following two years of infliximab remedy in sufferers with ankylosing spondylitis. Arthritis Rheum. 2008;58(10):3063–70.

    Article 
    PubMed 

    Google Scholar
     

  • van der Heijde D, Landewe R, Einstein S, Ory P, Vosse D, Ni L, Lin SL, Tsuji W, Davis JC Jr. Radiographic development of ankylosing spondylitis after as much as two years of therapy with etanercept. Arthritis Rheum. 2008;58(5):1324–31.

    Article 
    PubMed 

    Google Scholar
     

  • van der Heijde D, Salonen D, Weissman BN, Landewe R, Maksymowych WP, Kupper H, Ballal S, Gibson E, Wong R. g. canadian examine, A.s. group, Evaluation of radiographic development within the spines of sufferers with ankylosing spondylitis handled with adalimumab for as much as 2 years. Arthritis Res Ther. 2009;11(4):R127.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Bianco P, Robey PG, Simmons PJ. Mesenchymal stem cells: revisiting historical past, ideas, and assays. Cell Stem Cell. 2008;2(4):313–9.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Pineault KM, Track JY, Kozloff KM, Lucas D, Wellik DM. Hox11 expressing regional skeletal stem cells are progenitors for osteoblasts, chondrocytes and adipocytes all through life. Nat Commun. 2019;10(1):3168.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Zhou BO, Yue R, Murphy MM, Peyer JG, Morrison SJ. Leptin-receptor-expressing mesenchymal stromal cells characterize the principle supply of bone shaped by grownup bone marrow. Cell Stem Cell. 2014;15(2):154–68.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Bernardo ME, Fibbe WE. Mesenchymal stromal cells: sensors and switchers of irritation. Cell Stem Cell. 2013;13(4):392–402.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Zheng G, Xie Z, Wang P, Li J, Li M, Cen S, Tang S, Liu W, Ye G, Li Y, Wang S, Wu X, Su H, Wu Y, Shen H. Enhanced osteogenic differentiation of mesenchymal stem cells in ankylosing spondylitis: a examine based mostly on a three-dimensional biomimetic atmosphere. Cell Loss of life Dis. 2019;10(5):350.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Xie Z, Wang P, Li Y, Deng W, Zhang X, Su H, Li D, Wu Y, Shen H. Imbalance between bone morphogenetic protein 2 and Noggin induces irregular osteogenic differentiation of mesenchymal stem cells in Ankylosing Spondylitis. Arthritis Rheumatol. 2016;68(2):430–40.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Xie Z, Yu W, Zheng G, Li J, Cen S, Ye G, Li Z, Liu W, Li M, Lin J, Su Z, Che Y, Ye F, Wang P, Wu Y, Shen H. TNF-alpha-mediated m(6)a modification of ELMO1 triggers directional migration of mesenchymal stem cell in ankylosing spondylitis. Nat Commun. 2021;12(1):5373.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Li X, Wang J, Zhan Z, Li S, Zheng Z, Wang T, Zhang Okay, Pan H, Li Z, Zhang N, Liu H. Irritation intensity-dependent expression of Osteoinductive wnt proteins is vital for ectopic new bone formation in Ankylosing Spondylitis. Arthritis Rheumatol. 2018;70(7):1056–70.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Yang Y, Dai M. Expression of PADI4 in sufferers with ankylosing spondylitis and its function in mediating the consequences of TNF-alpha on the proliferation and osteogenic differentiation of human mesenchymal stem cells. Int J Mol Med. 2015;36(2):565–70.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Zubkova ES, Beloglazova IB, Makarevich PI, Boldyreva MA, Sukhareva OY, Shestakova MV, Dergilev KV, Parfyonova YV, Menshikov MY. Regulation of adipose tissue stem cells angiogenic potential by Tumor Necrosis factor-alpha. J Cell Biochem. 2016;117(1):180–96.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Blaser H, Dostert C, Mak TW, Brenner D. TNF and ROS crosstalk in irritation. Traits Cell Biol. 2016;26(4):249–61.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Li L, Lu Y, Xu X, Yang X, Chen L, Jiang C, Wang Y, Hu W, Wei X, Yang Z. Catalytic-enhanced lactoferrin-functionalized Au-Bi(2) Se(3) nanodots for Parkinson’s Illness Remedy through reactive oxygen attenuation and mitochondrial safety. Adv Healthc Mater. 2021;10(13):e2100316.

    Article 
    PubMed 

    Google Scholar
     

  • Yang Y, Guo L, Wang Z, Liu P, Liu X, Ding J, Zhou W. Focused silver nanoparticles for rheumatoid arthritis remedy through macrophage apoptosis and re-polarization. Biomaterials. 2021;264:120390.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Kumar S, Adjei IM, Brown SB, Liseth O, Sharma B. Manganese dioxide nanoparticles defend cartilage from inflammation-induced oxidative stress. Biomaterials. 2019;224:119467.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Kim J, Kim HY, Track SY, Go SH, Sohn HS, Baik S, Soh M, Kim Okay, Kim D, Kim HC, Lee N, Kim BS, Hyeon T. Synergistic oxygen era and reactive oxygen species scavenging by Manganese Ferrite/Ceria co-decorated nanoparticles for rheumatoid arthritis therapy. ACS Nano. 2019;13(3):3206–17.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Das S, Neal CJ, Ortiz J, Seal S. Engineered nanoceria cytoprotection in vivo: mitigation of reactive oxygen species and double-stranded DNA breakage resulting from radiation publicity. Nanoscale. 2018;10(45):21069–75.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Wang D, Goldring SR. The bone, the joints and the balm of Gilead. Mol Pharm. 2011;8(4):991–3.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Zhu G, Chen X. Aptamer-based focused remedy. Adv Drug Deliv Rev. 2018;134:65–78.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Petrocca F, Lieberman J. Promise and problem of RNA interference-based remedy for most cancers. J Clin Oncol. 2011;29(6):747–54.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Apparailly F, Jorgensen C. siRNA-based therapeutic approaches for rheumatic illnesses. Nat Rev Rheumatol. 2013;9(1):56–62.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Czech MP, Aouadi M, Tesz GJ. RNAi-based therapeutic methods for metabolic illness. Nat Rev Endocrinol. 2011;7(8):473–84.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Liang C, Guo B, Wu H, Shao N, Li D, Liu J, Dang L, Wang C, Li H, Li S, Lau WK, Cao Y, Yang Z, Lu C, He X, Au DW, Pan X, Zhang BT, Lu C, Zhang H, Yue Okay, Qian A, Shang P, Xu J, Xiao L, Bian Z, Tan W, Liang Z, He F, Zhang L, Lu A, Zhang G. Aptamer-functionalized lipid nanoparticles focusing on osteoblasts as a novel RNA interference-based bone anabolic technique, Nat Med 21(3) (2015) 288 – 94.

  • Cao F, Zhang L, Wang H, You Y, Wang Y, Gao N, Ren J, Qu X. Defect-Wealthy Adhesive Nanozymes as environment friendly antibiotics for enhanced bacterial inhibition. Angew Chem Int Ed Engl. 2019;58(45):16236–42.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Knop Okay, Hoogenboom R, Fischer D, Schubert US. Poly(ethylene glycol) in drug supply: execs and cons in addition to potential alternate options. Angew Chem Int Ed Engl. 2010;49(36):6288–308.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Zhao Z, Ukidve A, Kim J, Mitragotri S. Focusing on methods for tissue-specific drug supply. Cell. 2020;181(1):151–67.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Hess Okay, Ushmorov A, Fiedler J, Brenner RE, Wirth T. TNFalpha promotes osteogenic differentiation of human mesenchymal stem cells by triggering the NF-kappaB signaling pathway. Bone. 2009;45(2):367–76.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Hayden MS, Ghosh S. Regulation of NF-kappaB by TNF household cytokines. Semin Immunol. 2014;26(3):253–66.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Yu H, Lin L, Zhang Z, Zhang H, Hu H. Focusing on NF-kappaB pathway for the remedy of illnesses: mechanism and medical examine. Sign Transduct Goal Ther. 2020;5(1):209.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Denu RA, Hematti P. Results of Oxidative Stress on Mesenchymal Stem Cell Biology, Oxid Med Cell Longev 2016 (2016) 2989076.

  • Li Q, Gao Z, Chen Y, Guan MX. The function of mitochondria in osteogenic, adipogenic and chondrogenic differentiation of mesenchymal stem cells. Protein Cell. 2017;8(6):439–45.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Ruutu M, Thomas G, Steck R, Degli-Esposti MA, Zinkernagel MS, Alexander Okay, Velasco J, Strutton G, Tran A, Benham H, Rehaume L, Wilson RJ, Kikly Okay, Davies J, Pettit AR, Brown MA, McGuckin MA. Thomas, beta-glucan triggers spondylarthritis and Crohn’s disease-like ileitis in SKG mice. Arthritis Rheum. 2012;64(7):2211–22.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Sakaguchi N, Takahashi T, Hata H, Nomura T, Tagami T, Yamazaki S, Sakihama T, Matsutani T, Negishi I, Nakatsuru S, Sakaguchi S. Altered thymic T-cell choice resulting from a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature. 2003;426(6965):454–60.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Maillefert JF, Aho LS, El Maghraoui A, Dougados M, Roux C. Modifications in bone density in sufferers with ankylosing spondylitis: a two-year follow-up examine. Osteoporos Int. 2001;12(7):605–9.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Klingberg E, Lorentzon M, Mellstrom D, Geijer M, Gothlin J, Hilme E, Hedberg M, Carlsten H. Forsblad-d’Elia, osteoporosis in ankylosing spondylitis – prevalence, threat components and strategies of evaluation. Arthritis Res Ther. 2012;14(3):R108.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • van der Weijden MA, Claushuis TA, Nazari T, Lems WF, Dijkmans BA. Horst-Bruinsma, Excessive prevalence of low bone mineral density in sufferers inside 10 years of onset of ankylosing spondylitis: a scientific evaluate. Clin Rheumatol. 2012;31(11):1529–35. van der.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Keller KK, Lindgaard LM, Wogensen L, Dagnaes-Hansen F, Thomsen JS, Sakaguchi S, Stengaard-Pedersen Okay, Hauge EM. SKG arthritis as a mannequin for evaluating therapies in rheumatoid arthritis with particular give attention to bone modifications. Rheumatol Int. 2013;33(5):1127–33.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Shimizu T, Takahata M, Kimura-Suda H, Kameda Y, Endo Okay, Hamano H, Hiratsuka S, Ota M, Sato D, Ito T, Todoh M, Tadano S, Iwasaki N. Autoimmune arthritis deteriorates bone amount and high quality of periarticular bone in a mouse mannequin of rheumatoid arthritis. Osteoporos Int. 2017;28(2):709–18.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Rudwaleit M, van der Heijde D, Landewe R, Itemizing J, Akkoc N, Brandt J, Braun J, Chou CT, Collantes-Estevez E, Dougados M, Huang F, Gu J, Khan MA, Kirazli Y, Maksymowych WP, Mielants H, Sorensen IJ, Ozgocmen S, Roussou E, Valle-Onate R, Weber U, Wei J, Sieper J. The event of Evaluation of SpondyloArthritis worldwide Society classification standards for axial spondyloarthritis (half II): validation and last choice, Ann Rheum Dis 68(6) (2009) 777 – 83.

  • Appel H, Kuhne M, Spiekermann S, Kohler D, Zacher J, Stein H, Sieper J, Loddenkemper C. Immunohistochemical evaluation of hip arthritis in ankylosing spondylitis: analysis of the bone-cartilage interface and subchondral bone marrow. Arthritis Rheum. 2006;54(6):1805–13.

    Article 
    PubMed 

    Google Scholar
     

  • Klingberg E, Lorentzon M, Gothlin J, Mellstrom D, Geijer M, Ohlsson C, Atkinson EJ, Khosla S, Carlsten H. Forsblad-d’Elia, Bone microarchitecture in ankylosing spondylitis and the affiliation with bone mineral density, fractures, and syndesmophytes. Arthritis Res Ther. 2013;15(6):R179.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Wang CM, Tsai SC, Lin JC, Wu YJ, Wu J, Chen JY. Affiliation of genetic variants of RANK, RANKL, and OPG with Ankylosing Spondylitis Medical options in taiwanese. Mediators Inflamm. 2019;2019:8029863.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • Vernekar AA, Das T, Ghosh S, Mugesh G. A remarkably environment friendly MnFe2 O4 -based Oxidase Nanozyme. Chem Asian J. 2016;11(1):72–6.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Wang P, Li Y, Huang L, Yang J, Yang R, Deng W, Liang B, Dai L, Meng Q, Gao L, Chen X, Shen J, Tang Y, Zhang X, Hou J, Ye J, Chen Okay, Cai Z, Wu Y, Shen H. Results and security of allogenic mesenchymal stem cell intravenous infusion in lively ankylosing spondylitis sufferers who failed NSAIDs: a 20-week medical trial, Cell Transpl 23(10) (2014) 1293 – 303.

  • Hata H, Sakaguchi N, Yoshitomi H, Iwakura Y, Sekikawa Okay, Azuma Y, Kanai C, Moriizumi E, Nomura T, Nakamura T, Sakaguchi S. Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice. J Clin Make investments. 2004;114(4):582–8.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Leave a Reply

    Your email address will not be published. Required fields are marked *